Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Biomedical Sciences · India · 2025-09-02

Processing Time
561 days
Decision Date
2025-09-02
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in the field of biomedical sciences, specifically exploring molecular blueprints and cell signaling pathways. The work focuses on identifying new drug targets and diagnostic tools for devastating conditions such as Alzheimer’s disease and cancer. This research aims to develop precision therapies that improve public health outcomes through a better understanding of how cellular communication malfunctions.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in physiology and biophysics and a record of 11 peer-reviewed journal articles and 2 preprints with over 200 citations. Evidence included 8 peer review assignments, 4 expert recommendation letters, and proof of funding from the National Institutes of Health (NIH) and National Science Foundation (NSF). These factors satisfied the Dhanasar prongs by demonstrating the petitioner's influence and the national importance of the work.

Similar Cases

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 162 days 2025-12-23
The petitioner proposes to apply advanced molecular biology and multi-omics approaches to develop novel small-molecule inhibitors and RNA-based therapeutics. This work focuses on precisely targeting dysregulated signaling pathways to create therapeutic strategies for cancers, complex genetic disorders, and pathogen-induced infections.
View Case

Research Assistant

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
North Carolina 166 days 2025-02-04
The petitioner proposes to harness stem cell technology and material science to engineer accurate multicellular systems and novel therapies. This work focuses on addressing human organ shortages for transplant, creating better models for drug discovery, and designing advanced delivery systems for cardiovascular disease, chronic kidney disease, and cancer.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · Egypt

WeGreened EB-2 (NIW) rfe approved
Connecticut 428 days 2025-08-14
The petitioner proposes to advance cutting-edge experimental and computational methods to enable a deeper understanding of biomolecular mechanisms underlying disease. This work investigates the behaviors of biomolecules, cells, and tissues to develop revolutionary diagnostic tools and therapeutic strategies for cancer and congenital disabilities.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 561 days

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist